High-resolution melt curve analysis for rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a single-centre study in Iran

High-resolution melt curve analysis for rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a single-centre study in Iran

This study aimed to compare the diagnostic accuracy of high-resolution melting (HRM) analysis in comparison with Xpert MTB/RIF as well as conventional drug susceptibility testing (DST) for the detection of rifampicin (RIF) resistance in Mycobacterium tuberculosis in Iran. A comparative cross-section...

Full description

Bibliographic Details
Main Authors:	S. Arefzadeh, T. Azimi, M.J. Nasiri, Z. Nikpor, H. Dabiri, F. Doustdar, H. Goudarzi, M. Allahyartorkaman
Format:	Article
Language:	English
Published:	Elsevier 2020-05-01
Series:	New Microbes and New Infections
Subjects:	High-resolution melting analysis Iran rifampicin resistance tuberculosis Xpert MTB/RIF
Online Access:	http://www.sciencedirect.com/science/article/pii/S2052297520300172

Similar Items

Rifampicin resistance in Mycobacterium tuberculosis in Iran: a two-centre study
by: F. Bahraminia, et al.
Published: (2021-07-01)

Pattern of Mutations in Rifampicin Resistance (rpoB) Gene and Analysis of Rifampicin Indeterminate Result in Tuberculosis Detected by Xpert MTB/RIF Assay in Kalaburagi, India
by: M. Ravish Kumar, et al.
Published: (2024-06-01)

High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana
by: Justice K Boakye-Appiah, et al.
Published: (2016-01-01)

Comparison of Nucleotide MALDI-TOF MS with Xpert MTB/RIF for Rifampicin Susceptibility Identification and Associated Risk Factors of Rifampicin Resistance Among Drug Resistant Mycobacterium tuberculosis
by: Song S, et al.
Published: (2024-09-01)

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
by: Yeliz Tanriverdi Cayci, et al.

Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia
by: Mulualem Tadesse, et al.
Published: (2016-01-01)

Age and sex distribution of Mycobacterium tuberculosis infection and rifampicin resistance in Myanmar as detected by Xpert MTB/RIF
by: Marva Seifert, et al.
Published: (2021-08-01)

Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda
by: Willy Ssengooba, et al.
Published: (2021-12-01)

Mycobacterium tuberculosis and rifampicin-resistant tuberculosis among tuberculosis presumptive patients in selected zones of Tigray, Northern Ethiopia, 2016–2019
by: Tsehaye Asmelash Dejene, et al.
Published: (2024-07-01)

Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis
by: Kaican Zong, et al.
Published: (2019-08-01)

Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China
by: Zheyuan Wu, et al.
Published: (2020-02-01)

Pulmonary Tuberculosis and Rifampicin Resistant Mycobacterium Tuberculosis in Children and Adolescents using Gene Xpert MTB/RIF Assay in Tigray, Northern Ethiopia
by: Dejene TA, et al.
Published: (2023-10-01)

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
by: Julia V. Ershova, et al.
Published: (2020-07-01)

Comparative Studies of the Methods of Detecting Rifampicin Resistant Mycobacterium tuberculosis among Tuberculosis Patients Attending Aminu Kano Teaching Hospital, Kano
by: Hamza, J.A., et al.
Published: (2021-12-01)

Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia
by: Ayinalem Alemu, et al.
Published: (2020-01-01)

Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
by: Asmaa Mohammed Elbrolosy, et al.
Published: (2021-05-01)

XPERT MTB/RIF TEST FOR THE DIAGNOSIS OF TUBERCULOSIS AND RIFAMPICIN RESISTANCE: RESULTS OF ITS INTRODUCTION IN THE KYRGYZ REPUBLIC
by: A. D. Adambekova, et al.
Published: (2014-01-01)

Prevalence of rifampicin resistant pulmonary tuberculosis using geneXpert assay in Ethiopia, a systematic review and meta-analysis
by: Maritu Demelash, et al.
Published: (2023-09-01)

GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis
by: Leen Rigouts, et al.
Published: (2023-07-01)

A pilot study on the genetic diversity of Mycobacterium tuberculosis complex strains from tuberculosis patients in the Littoral region of Cameroon
by: Benjamin D. Thumamo Pokam, et al.
Published: (2020-12-01)

Xpert MTB/RIF Ultra Assay Using Stool: an Effective Solution for Bacilli Identification from Adult Pulmonary Tuberculosis Suspects without Expectorated Sputum
by: Xia Yu, et al.
Published: (2023-08-01)

Bridging the TB data gap: in silico extraction of rifampicin-resistant tuberculosis diagnostic test results from whole genome sequence data
by: Kamela C. S. Ng, et al.
Published: (2019-08-01)

Sociodemographic profile of mono rifampicin-resistant (RR) cases among pulmonary tuberculosis patients, Erbil, Iraq, 2015–2020
by: Sharmeen Qadr Faqi Abdullah
Published: (2022-01-01)

Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
by: Armand Van Deun, et al.
Published: (2021-05-01)

HIV-Negative Rifampicin Resistance/Multidrug-Resistant Extrapulmonary Tuberculosis in China from 2015 to 2019: A Clinical Retrospective Investigation Study from a National Tuberculosis Clinical Research Center
by: Ma J, et al.
Published: (2022-03-01)

More Than a Decade of GeneXpert<sup>®</sup> <i>Mycobacterium tuberculosis</i>/Rifampicin (Ultra) Testing in South Africa: Laboratory Insights from Twenty-Three Million Tests
by: Manuel Pedro da Silva, et al.
Published: (2023-10-01)

Xpert MTB/RIF Ultra assay for the detection of Mycobacterium tuberculosis in people with negative conventional Xpert MTB/RIF but chest imaging suggestive of tuberculosis in Dhaka, Bangladesh
by: Samanta Biswas, et al.
Published: (2022-01-01)

The Role of GeneXpert<sup>®</sup> for Tuberculosis Diagnostics in Brazil: An Examination from a Historical and Epidemiological Perspective
by: Tirça Naiara da Silva Iúdice, et al.
Published: (2023-10-01)

Diagnostic Performance of Xpert MTB/RIF Ultra Compared with Predecessor Test, Xpert MTB/RIF, in a Low TB Incidence Setting: a Retrospective Service Evaluation
by: Mary Mansfield, et al.
Published: (2022-06-01)

Efficacy of the Xpert Mycobacterium tuberculosis/rifampicin assay for diagnosing sputum-smear negative or sputum-scarce pulmonary tuberculosis in bronchoalveolar lavage fluid
by: Juan Yang, et al.
Published: (2021-06-01)

Epidemiology and outcome of rifampicin resistant tuberculosis in Upper Egypt
by: Shereen Farghaly, et al.
Published: (2021-01-01)

Prevalence of Tuberculosis by Automated GeneXpert Rifampicin Assay and Associated Risk Factors Among Presumptive Pulmonary Tuberculosis Patients at Ataye District Hospital, North East Ethiopia
by: Gebretsadik D, et al.
Published: (2020-05-01)

Analysis of Drug-Resistant Tuberculosis in Children in Shenyang, China, 2017–2021
by: Sun J, et al.
Published: (2023-11-01)

Sequential testing with Xpert MTB/RIF assay for diagnosis of tuberculous meningitis in Maharaj Nakorn Chiang Mai University Hospital
by: Poramed Winichakoon, et al.
Published: (2025-01-01)

Implementation of the Xpert MTB/RIF assay for tuberculosis in Mongolia: a qualitative exploration of barriers and enablers
by: Nicole L. Rendell, et al.
Published: (2017-07-01)

Study of diagnostic utility of Xpert MTB/Rif test on pleural fluid in the evaluation of patients presenting with Pleural Tuberculosis in Nepal
by: Deebya Raj Mishra, et al.
Published: (2022-01-01)

Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020-07-01)

Phenotypic drug susceptibility characterization and clinical outcomes of tuberculosis strains with A-probe mutation by GeneXpert MTB/RIF
by: Qi Nie, et al.
Published: (2023-11-01)

Is Xpert MTB/RIF appropriate for diagnosing tuberculous pleurisy with pleural fluid samples? A systematic review
by: Zhen-yu Huo, et al.
Published: (2018-06-01)

Performance of the MeltPro TB assay as initial test for diagnosis of pulmonary tuberculosis with drug-resistance detection
by: Zhi-bin Liu, et al.
Published: (2023-11-01)